Patient Convenience Study- NIS RELATE


Phase N/A Results N/A

Summary of Purpose

The aim of this non-interventional study is to describe patient's perception of anticoagulant treatment when using Pradaxa® to prevent stroke and systemic embolism while suffering from atrial fibrillation (according to its approved indication in the approved dosages of 110 mg or 150 mg twice daily) in comparison to standard care using Vitamin K Antagonist (VKA).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 January 2018.

20 Jun 2016 4 May 2016 30 Dec 2017 30 Dec 2017 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample